G
Galectin Therapeutics Inc. (GALT)
NCM – Real Time Price. Currency in USD
2.25
+0.04 (1.81%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.25
+0.04 (1.81%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.42 | 6.05 | 10 | |
| Quick ratio | 2.42 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 6.85 | 1.04 | 1.0 | |
| Interest coverage | -1.74 | -16.91 | 1.0 | |
| Weighted average score | 4.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -32K | -33K | -37K | -53K | -53K |
| Operating Income | -38M | -38M | -42M | -20M | -20M |
| Net Income | -39M | -41M | -47M | -31M | -31M |
| EBITDA | -38M | -38M | -42M | -20M | -20M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 60 | 5.5 |
| Next quarter | N/A | 41.67 | 5.5 |
| Current year | N/A | 35.42 | 5.5 |
| Next year | N/A | -6.45 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 32.8 | 38.46 | -70.57 | 7.8 |
| Y/Y | 999 | 54.04 | 57.89 | 52.76 | 10 |
| 3y average | 999 | 4.67 | 6.77 | 3.34 | 5.8 |
| 5y average | 999 | -8.61 | -6.29 | -7.13 | 3.3 |
| Weighted average score | 6.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $133.8M significantly exceeds cash reserves ($17.7M), raising financial stability concerns
Total current assets $19.4M exceed Total current liabilities $8.0M, highlighting excellent liquidity
Debt-to-equity ratio (-1.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$6.0M limits the company's ability to reinvest or pay down debt